Cancer-like metabolism of the mammalian retina

Clinical and Experimental Ophthalmology

Volumn 43, Issue 4, 2015, Pages 367-376

  Ng, Soo Khai ^a   Wood, John P M ^a   Chidlow, Glyn ^a   Han, Guoge ^a   Kittipassorn, Thaksaon ^a,b   Peet, Daniel J ^a   Casson, Robert J ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Aerobic glycolysis; HIF 1; Mammalian retina; PKM2; Warburg effect

Indexed keywords

ANTINEOPLASTIC AGENT; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LACTATE DEHYDROGENASE; LACTIC ACID; PROTEIN PKM2; PYRUVATE KINASE; UNCLASSIFIED DRUG; OXYGEN;

ADVERSE OUTCOME; ANAEROBIC GLYCOLYSIS; CANCER RESEARCH; CANCER THERAPY; CELL METABOLISM; CELL PROLIFERATION; ENERGY METABOLISM; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MAMMAL; METABOLIC RATE; MOLECULAR BIOLOGY; MUELLER CELL; NONHUMAN; NUCLEAR REPROGRAMMING; OXIDATIVE PHOSPHORYLATION; RETINA; RETINA GANGLION CELL; REVIEW; TUMOR CELL; WARBURG EFFECT; ANIMAL; GLYCOLYSIS; METABOLISM; NEOPLASM; PHYSIOLOGY;

ANIMALS; ENERGY METABOLISM; GLYCOLYSIS; HUMANS; NEOPLASMS; OXIDATIVE PHOSPHORYLATION; OXYGEN; PYRUVATE KINASE; RETINA;

EID: 84932188455     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/ceo.12462     Document Type: Review

References (112)

1. Dixon KC. The pasteur effect and its mechanism. Biol Rev 1937; 12: 393-503.
2. Winkler BS, Sauer MW, Starnes CA. Modulation of the Pasteur effect in retinal cells: implications for understanding compensatory metabolic mechanisms. Exp Eye Res 2003; 76: 715-723.
3. Warburg O. On the origin of cancer cells. Science 1956; 123: 309-314.
4. Wind F. In: Warburg O, ed. The Metabolism of Tumors: Investigations from the Kaiser Wilhelm Institute for Biology. Berlin-Dahlem, London: Constable & Co. Ltd., 1930; 282.
5. Noell WK. The effect of iodoacetate on the vertebrate retina. J Cell Physiol 1951; 37: 283-307.
6. Winkler BS. Glycolytic and oxidative metabolism in relation to retinal function. J Gen Physiol 1981; 77: 667-692.
7. Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer 2011; 11: 85-95.
8. Christofk HR, Vander Heiden MG, Harris MH etal. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008; 452: 230-233.
9. Luo W, Hu H, Chang R etal. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 2011; 145: 732-744.
10. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324: 1029-1033.
11. Casson RJ, Chidlow G, Han G, Wood JP. An explanation for the Warburg effect in the adult mammalian retina. Clin Exp Ophthalmol 2013; 41: 517.
12. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004; 4: 891-899.
13. Palsson-McDermott EM, O'Neill LA. The Warburg effect then and now: from cancer to inflammatory diseases. Bioessays 2013; 35: 965-973.
14. Krawczyk CM, Holowka T, Sun J etal. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 2010; 115: 4742-4749.
15. Romano AH, Conway T. Evolution of carbohydrate metabolic pathways. Res Microbiol 1996; 147: 448-455.
16. Imamura K, Tanaka T. Multimolecular forms of pyruvate kinase from rat and other mammalian tissues. I. Electrophoretic studies. J Biochem 1972; 71: 1043-1051.
17. Berg JM, Tymoczko JL, Stryer L. Biochemistry. 5th edition. New York: W H Freeman; 2002. Section 18.6, The Regulation of Cellular Respiration Is Governed Primarily by the Need for ATP. http://www.ncbi.nlm.nih.gov/books/NBK22448/
18. Lehninger A, N DL, Cox MM. Principles of Biochemistry, 2nd edn. New York: Worth, 1993.
19. Zheng L, Roeder RG, Luo Y. S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component. Cell 2003; 114: 255-266.
20. Rathmell JC, Fox CJ, Plas DR, Hammerman PS, Cinalli RM, Thompson CB. Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival. Mol Cell Biol 2003; 23: 7315-7328.
21. Sun YJ, Chou CC, Chen WS, Wu RT, Meng M, Hsiao CD. The crystal structure of a multifunctional protein: phosphoglucose isomerase/autocrine motility factor/neuroleukin. Proc Natl Acad Sci U S A 1999; 96: 5412-5417.
22. Jones RG, Thompson CB. Revving the engine: signal transduction fuels T cell activation. Immunity 2007; 27: 173-178.
23. Weinhouse S. The Warburg hypothesis fifty years later. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol 1976; 87: 115-126.
24. Fantin VR, St-Pierre J, Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 2006; 9: 425-434.
25. Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell 2012; 21: 297-308.
26. Collet JF, Stroobant V, Van Schaftingen E. Mechanistic studies of phosphoserine phosphatase, an enzyme related to P-type ATPases. J Biol Chem 1999; 274: 33985-33990.
27. Mazurek S. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells. Int J Biochem Cell Biol 2011; 43: 969-980.
28. Lum JJ, Bui T, Gruber M etal. The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis. Genes Dev 2007; 21: 1037-1049.
29. Majumder PK, Febbo PG, Bikoff R etal. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. Nat Med 2004; 10: 594-601.
30. Ramanathan A, Schreiber SL. Direct control of mitochondrial function by mTOR. Proc Natl Acad Sci U S A 2009; 106: 22229-22232.
31. Buzzai M, Bauer DE, Jones RG etal. The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation. Oncogene 2005; 24: 4165-4173.
32. Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Mootha VK, Puigserver P. mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 2007; 450: 736-740.
33. Dang CV. Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. Cancer Res 2010; 70: 859-862.
34. Bach M, Hawlina M, Holder GE etal. Standard for pattern electroretinography. International Society for Clinical Electrophysiology of Vision. Doc Ophthalmol 2000; 101: 11-18.
35. Wang HJ, Hsieh YJ, Cheng WC etal. JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1alpha-mediated glucose metabolism. Proc Natl Acad Sci U S A 2014; 111: 279-284.
36. Goda N, Kanai M. Hypoxia-inducible factors and their roles in energy metabolism. Int J Hematol 2012; 95: 457-463.
37. Ke Q, Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 2006; 70: 1469-1480.
38. Eigenbrodt E, Reinacher M, Scheefers-Borchel U, Scheefers H, Friis R. Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells. Crit Rev Oncog 1992; 3: 91-115.
39. Jurica MS, Mesecar A, Heath PJ, Shi W, Nowak T, Stoddard BL. The allosteric regulation of pyruvate kinase by fructose-1, 6-bisphosphate. Structure 1998; 6: 195-210.
40. Dombrauckas JD, Santarsiero BD, Mesecar AD. Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis. Biochemistry 2005; 44: 9417-9429.
41. Spoden GA, Rostek U, Lechner S, Mitterberger M, Mazurek S, Zwerschke W. Pyruvate kinase isoenzyme M2 is a glycolytic sensor differentially regulating cell proliferation, cell size and apoptotic cell death dependent on glucose supply. Exp Cell Res 2009; 315: 2765-2774.
42. Anastasiou D, Yu Y, Israelsen WJ etal. Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis. Nat Chem Biol 2012; 8: 839-847.
43. Lv L, Li D, Zhao D etal. Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth. Mol Cell 2011; 42: 719-730.
44. Bluemlein K, Gruning NM, Feichtinger RG, Lehrach H, Kofler B, Ralser M. No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis. Oncotarget 2011; 2: 393-400.
45. Luo W, Semenza GL. Pyruvate kinase M2 regulates glucose metabolism by functioning as a coactivator for hypoxia-inducible factor 1 in cancer cells. Oncotarget 2011; 2: 551-556.
46. Keller KE, Tan IS, Lee YS. SAICAR stimulates pyruvate kinase isoform M2 and promotes cancer cell survival in glucose-limited conditions. Science 2012; 338: 1069-1072.
47. Yang W, Zheng Y, Xia Y etal. ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect. Nat Cell Biol 2012; 14: 1295-1304.
48. Cortes-Cros M, Hemmerlin C, Ferretti S etal. M2 isoform of pyruvate kinase is dispensable for tumor maintenance and growth. Proc Natl Acad Sci U S A 2013; 110: 489-494.
49. Israelsen WJ, Dayton TL, Davidson SM etal. PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells. Cell 2013; 155: 397-409.
50. Vander Heiden MG, Locasale JW, Swanson KD etal. Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science 2010; 329: 1492-1499.
51. Ames A III, Li YY, Heher EC, Kimble CR. Energy metabolism of rabbit retina as related to function: high cost of Na+transport. J Neurosci 1992; 12: 840-853.
52. Noell WK. The visual cell: electric and metabolic manifestations of its life processes. Am J Ophthalmol 1959; 48 (Pt 2): 347-370.
53. Cohen LH, Noell WK. Glucose catabolism of rabbit retina before and after development of visual function. J Neurochem 1960; 5: 253-276.
54. Tornquist P, Alm A. Retinal and choroidal contribution to retinal metabolism in vivo. A study in pigs. Acta Physiol Scand 1979; 106: 351-357.
55. Winkler BS. The electroretinogram of the isolated rat retina. Vision Res 1972; 12: 1183-1198.
56. Wang L, Bill A. Effects of constant and flickering light on retinal metabolism in rabbits. Acta Ophthalmol Scand 1997; 75: 227-231.
57. Winkler BS. A quantitative assessment of glucose metabolism in the isolated rat retina. In: Christen Y, Doly M, Droy-Lefaix M-T, eds. A Quantitative Assessment of Glucose Metabolism in the Isolated Rat Retina. Amsterdam: Elsevier, 1995; 78-96.
58. Graymore C. Metabolism of the developing retina. III. Respiration in the developing normal rat retina and the effect of an inherited degeneration of the retinal neuroepithelium. Br J Ophthalmol 1960; 44: 363-369.
59. Graymore C. Metabolism of the developing retina. I. Aerobic and anaerobic glycolysis in the developing rat retina. Br J Ophthalmol 1959; 43: 34-39.
60. Wang L, Tornquist P, Bill A. Glucose metabolism in pig outer retina in light and darkness. Acta Physiol Scand 1997; 160: 75-81.
61. Wang L, Tornquist P, Bill A. Glucose metabolism of the inner retina in pigs in darkness and light. Acta Physiol Scand 1997; 160: 71-74.
62. Linsenmeier RA. Effects of light and darkness on oxygen distribution and consumption in the cat retina. J Gen Physiol 1986; 88: 521-542.
63. Haugh LM, Linsenmeier RA, Goldstick TK. Mathematical models of the spatial distribution of retinal oxygen tension and consumption, including changes upon illumination. Ann Biomed Eng 1990; 18: 19-36.
64. Yu DY, Cringle SJ. Oxygen distribution and consumption within the retina in vascularised and avascular retinas and in animal models of retinal disease. Prog Retin Eye Res 2001; 20: 175-208.
65. Winkler BS, Arnold MJ, Brassell MA, Puro DG. Energy metabolism in human retinal Muller cells. Invest Ophthalmol Vis Sci 2000; 41: 3183-3190.
66. Bui BV, He Z, Vingrys AJ, Nguyen CT, Wong VH, Fortune B. Using the electroretinogram to understand how intraocular pressure elevation affects the rat retina. J Ophthalmol 2013; 2013: 262467.
67. Noell WK. Site of asphyxial block in mammalian retinae. J Appl Physiol 1951; 3: 489-500.
68. Casson RJ, Chidlow G, Wood JP, Osborne NN. The effect of hyperglycemia on experimental retinal ischemia. Arch Ophthalmol 2004; 122: 361-366.
69. Holman MC, Chidlow G, Wood JP, Casson RJ. The effect of hyperglycemia on hypoperfusion-induced injury. Invest Ophthalmol Vis Sci 2010; 51: 2197-2207.
70. Ebneter A, Chidlow G, Wood JP, Casson RJ. Protection of retinal ganglion cells and the optic nerve during short-term hyperglycemia in experimental glaucoma. Arch Ophthalmol 2011; 129: 1337-1344.
71. Han G, Wood JP, Chidlow G, Mammone T, Casson RJ. Mechanisms of neuroprotection by glucose in rat retinal cell cultures subjected to respiratory inhibition. Invest Ophthalmol Vis Sci 2013; 54: 7567-7577.
72. Winkler BS, Starnes CA, Sauer MW, Firouzgan Z, Chen SC. Cultured retinal neuronal cells and Muller cells both show net production of lactate. Neurochem Int 2004; 45: 311-320.
73. Van Bergen NJ, Wood JP, Chidlow G etal. Recharacterization of the RGC-5 retinal ganglion cell line. Investe Ophthalmol Vis Sci 2009; 50: 4267-4272.
74. Wood JP, Chidlow G, Tran T, Crowston JG, Casson RJ. A comparison of differentiation protocols for RGC-5 cells. Invest Ophthalmol Vis Sci 2010; 51: 3774-3783.
75. Hartong DT, Dange M, McGee TL, Berson EL, Dryja TP, Colman RF. Insights from retinitis pigmentosa into the roles of isocitrate dehydrogenases in the Krebs cycle. Nat Genet 2008; 40: 1230-1234.
76. Donovan M, Carmody RJ, Cotter TG. Light-induced photoreceptor apoptosis in vivo requires neuronal nitric-oxide synthase and guanylate cyclase activity and is caspase-3-independent. J Biol Chem 2001; 276: 23000-23008.
77. Sanz MM, Johnson LE, Ahuja S, Ekstrom PA, Romero J, van Veen T. Significant photoreceptor rescue by treatment with a combination of antioxidants in an animal model for retinal degeneration. Neuroscience 2007; 145: 1120-1129.
78. Sanvicens N, Gomez-Vicente V, Masip I, Messeguer A, Cotter TG. Oxidative stress-induced apoptosis in retinal photoreceptor cells is mediated by calpains and caspases and blocked by the oxygen radical scavenger CR-6. J Biol Chem 2004; 279: 39268-39278.
79. Krebs W, Kuhn H. Structure of isolated bovine rod outer segment membranes. Exp Eye Res 1977; 25: 511-526.
80. Young RW. The renewal of rod and cone outer segments in the rhesus monkey. J Cell Biol 1971; 49: 303-318.
81. Young RW. Proceedings: biogenesis and renewal of visual cell outer segment membranes. Exp Eye Res 1974; 18: 215-223.
82. Hargrave PA, Fong SL, Hugh McDowell J etal. The partial primary structure of bovine rhodopsin and its topography in the retinal rod cell disc membrane. Neurochem Int 1980; 1C: 231-244.
83. Young RW. The renewal of photoreceptor cell outer segments. J Cell Biol 1967; 33: 61-72.
84. Agathocleous M, Love NK, Randlett O etal. Metabolic differentiation in the embryonic retina. Nat Cell Biol 2012; 14: 859-864.
85. De Robertis E. Electron microscope observations on the submicroscopic organization of the retinal rods. J Biophys Biochem Cytol 1956; 2: 319-330.
86. Sjostrand FS. The ultrastructure of the innersegments of the retinal rods of the guinea pig eye as revealed by electron microscopy. J Cell Physiol 1953; 42: 45-70.
87. Sjostrand FS. The ultrastructure of the outer segments of rods and cones of the eye as revealed by the electron microscope. J Cell Physiol 1953; 42: 15-44.
88. Lowry OH, Roberts NR, Lewis C. The quantitative histochemistry of the retina. J Biol Chem 1956; 220: 879-892.
89. Kuwabara T, Cogan DG. Retinal glycogen. Arch Ophthalmol 1961; 66: 680-688.
90. Pellerin L, Magistretti PJ. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci U S A 1994; 91: 10625-10629.
91. Chih CP, Roberts EL Jr. Energy substrates for neurons during neural activity: a critical review of the astrocyte-neuron lactate shuttle hypothesis. J Cereb Blood Flow Metab 2003; 23: 1263-1281.
92. Das AV, Mallya KB, Zhao X etal. Neural stem cell properties of Muller glia in the mammalian retina: regulation by Notch and Wnt signaling. Dev Biol 2006; 299: 283-302.
93. Giannelli SG, Demontis GC, Pertile G, Rama P, Broccoli V. Adult human Muller glia cells are a highly efficient source of rod photoreceptors. Stem Cells 2011; 29: 344-356.
94. Chung SH, Shen W, Gillies MC. Laser capture microdissection-directed profiling of glycolytic and mTOR pathways in areas of selectively ablated Muller cells in the murine retina. Invest Ophthalmol Vis Sci 2013; 54: 6578-6585.
95. Cahn RD, Zwilling E, Kaplan NO, Levine L. Nature and development of lactic dehydrogenases: the two major types of this enzyme form molecular hybrids which change in makeup during development. Science 1962; 136: 962-969.
96. Plagemann PG, Gregory KF, Wroblewski F. The electrophoretically distinct forms of mammalian lactic dehydrogenase. 1. Distribution of lactic dehydrogenase. 1. Distribution of lactic dehydrogenases in rabbit and human tissue. J Biol Chem 1960; 235: 2282-2287.
97. Miao P, Sheng S, Sun X, Liu J, Huang G. Lactate dehydrogenase a in cancer: a promising target for diagnosis and therapy. IUBMB Life 2013; 65: 904-910.
98. Graymore C. Possible significance of the isoenzymes of lactic dehydrogenase in the retina of the rat. Nature 1964; 201: 615-616.
99. Saavedra RA, Anderson GR. A cancer-associated lactate dehydrogenase is expressed in normal retina. Science 1983; 221: 291-292.
100. Saavedra RA, Cordoba C, Anderson GR. LDHk in the retina of diverse vertebrate species: a possible link to the Warburg effect. Exp Eye Res 1985; 41: 365-370.
101. Hughes JM, Groot AJ, van der Groep P etal. Active HIF-1 in the normal human retina. J Histochem Cytochem 2010; 58: 247-254.
102. Morohoshi K, Ohbayashi M, Patel N, Chong V, Bird AC, Ono SJ. Identification of anti-retinal antibodies in patients with age-related macular degeneration. Exp Mol Pathol 2012; 93: 193-199.
103. Yang CM, Liu YZ, Liao JW, Hu ML. The in vitro and in vivo anti-metastatic efficacy of oxythiamine and the possible mechanisms of action. Clin Exp Metastasis 2010; 27: 341-349.
104. Evans MJ, Saghatelian A, Sorensen EJ, Cravatt BF. Target discovery in small-molecule cell-based screens by in situ proteome reactivity profiling. Nat Biotechnol 2005; 23: 1303-1307.
105. Le A, Cooper CR, Gouw AM etal. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci U S A 2010; 107: 2037-2042.
106. Sonveaux P, Vegran F, Schroeder T etal. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 2008; 118: 3930-3942.
107. Oudard S, Carpentier A, Banu E etal. Phase II study of lonidamine and diazepam in the treatment of recurrent glioblastoma multiforme. J Neurooncol 2003; 63: 81-86.
108. De Lena M, Lorusso V, Latorre A etal. Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study. Eur J Cancer 2001; 37: 364-368.
109. Vander Heiden MG, Christofk HR, Schuman E etal. Identification of small molecule inhibitors of pyruvate kinase M2. Biochem Pharmacol 2010; 79: 1118-1124.
110. Chen J, Xie J, Jiang Z, Wang B, Wang Y, Hu X. Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2. Oncogene 2011; 30: 4297-4306.
111. Boxer MB, Jiang JK, Vander Heiden MG etal. Evaluation of substituted N, N'-diarylsulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase. J Med Chem 2010; 53: 1048-1055.
112. Ng SK, Wood JP, Chidlow G, Peet DJ, Casson RJ. Potential adverse effects to the retina of cancer therapy targeting pyruvate kinase M2. Acta Oncol (Madr) 2014; 1-2.